Please Wait
Applying Filters...
menu
    • menu
    PharmaCompass Sponsored Ads

    Virtual Booth

    Contact Supplier

    Sharp is a global leader in pharmaceutical packaging and clinical trial supply services.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2025-04-21

    Virtual Booth

    Contact Supplier

    PharmaCompass Sponsored Ads

    Virtual Booth

    Contact Supplier

    USP reference standards; highly characterized specimens of drug substances, impurities, excipients, degradation products & more.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2025-04-14

    Virtual Booth

    Contact Supplier

    Menu

    Venvanse

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 4,050Xls

    Filters

    clear-filterReset all filters
    Filters Filter
    Cross PopUp
    FILTER :

    filter clear-filterReset all filters

    01 7APOTEX INC

    02 7PRO DOC LIMITEE

    03 7SANDOZ CANADA INCORPORATED

    04 13TAKEDA CANADA INC

    05 6TARO PHARMACEUTICALS INC

    06 7TEVA CANADA LIMITED

    filter clear-filterReset all filters

    filter clear-filterReset all filters

    filter clear-filterReset all filters

    PharmaCompass
    ListList of Suppliers
    refreshReset Filter
    refresh Reset Filter
    Price Info Price Info
    product-page Product Main Page

    01

    TAKEDA CANADA INC

    Japan
    MAGHREB PHARMA
    Not Confirmed
    arrow

    TAKEDA CANADA INC

    Japan
    arrow
    MAGHREB PHARMA
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag Japan
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : Schedule G (CDSA I)

    Registration Country : Canada

    LISDEXAMFETAMINE DIMESYLATE

    Brand Name : VYVANSE

    Dosage Form : CAPSULE

    Dosage Strength : 50MG

    Packaging : 100

    Approval Date :

    Application Number : 2322978

    Regulatory Info : Schedule G (CDSA I)

    Registration Country : Canada

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    02

    TAKEDA CANADA INC

    Japan
    MAGHREB PHARMA
    Not Confirmed
    arrow

    TAKEDA CANADA INC

    Japan
    arrow
    MAGHREB PHARMA
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag Japan
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : Schedule G (CDSA I)

    Registration Country : Canada

    LISDEXAMFETAMINE DIMESYLATE

    Brand Name : VYVANSE

    Dosage Form : CAPSULE

    Dosage Strength : 30MG

    Packaging : 100

    Approval Date :

    Application Number : 2322951

    Regulatory Info : Schedule G (CDSA I)

    Registration Country : Canada

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    03

    TAKEDA CANADA INC

    Japan
    MAGHREB PHARMA
    Not Confirmed
    arrow

    TAKEDA CANADA INC

    Japan
    arrow
    MAGHREB PHARMA
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag Japan
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : Schedule G (CDSA I)

    Registration Country : Canada

    LISDEXAMFETAMINE DIMESYLATE

    Brand Name : VYVANSE

    Dosage Form : CAPSULE

    Dosage Strength : 70MG

    Packaging : 100

    Approval Date :

    Application Number : 2458071

    Regulatory Info : Schedule G (CDSA I)

    Registration Country : Canada

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    04

    TAKEDA CANADA INC

    Japan
    MAGHREB PHARMA
    Not Confirmed
    arrow

    TAKEDA CANADA INC

    Japan
    arrow
    MAGHREB PHARMA
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag Japan
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : Schedule G (CDSA I)

    Registration Country : Canada

    LISDEXAMFETAMINE DIMESYLATE

    Brand Name : VYVANSE

    Dosage Form : TABLET (CHEWABLE)

    Dosage Strength : 10MG

    Packaging :

    Approval Date :

    Application Number : 2490226

    Regulatory Info : Schedule G (CDSA I)

    Registration Country : Canada

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    05

    TAKEDA CANADA INC

    Japan
    MAGHREB PHARMA
    Not Confirmed
    arrow

    TAKEDA CANADA INC

    Japan
    arrow
    MAGHREB PHARMA
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag Japan
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : Schedule G (CDSA I)

    Registration Country : Canada

    LISDEXAMFETAMINE DIMESYLATE

    Brand Name : VYVANSE

    Dosage Form : TABLET (CHEWABLE)

    Dosage Strength : 20MG

    Packaging :

    Approval Date :

    Application Number : 2490234

    Regulatory Info : Schedule G (CDSA I)

    Registration Country : Canada

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    06

    TAKEDA CANADA INC

    Japan
    MAGHREB PHARMA
    Not Confirmed
    arrow

    TAKEDA CANADA INC

    Japan
    arrow
    MAGHREB PHARMA
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag Japan
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : Schedule G (CDSA I)

    Registration Country : Canada

    LISDEXAMFETAMINE DIMESYLATE

    Brand Name : VYVANSE

    Dosage Form : TABLET (CHEWABLE)

    Dosage Strength : 30MG

    Packaging :

    Approval Date :

    Application Number : 2490242

    Regulatory Info : Schedule G (CDSA I)

    Registration Country : Canada

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    07

    TAKEDA CANADA INC

    Japan
    MAGHREB PHARMA
    Not Confirmed
    arrow

    TAKEDA CANADA INC

    Japan
    arrow
    MAGHREB PHARMA
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag Japan
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : Schedule G (CDSA I)

    Registration Country : Canada

    LISDEXAMFETAMINE DIMESYLATE

    Brand Name : VYVANSE

    Dosage Form : TABLET (CHEWABLE)

    Dosage Strength : 40MG

    Packaging :

    Approval Date :

    Application Number : 2490250

    Regulatory Info : Schedule G (CDSA I)

    Registration Country : Canada

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    08

    TAKEDA CANADA INC

    Japan
    MAGHREB PHARMA
    Not Confirmed
    arrow

    TAKEDA CANADA INC

    Japan
    arrow
    MAGHREB PHARMA
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag Japan
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : Schedule G (CDSA I)

    Registration Country : Canada

    LISDEXAMFETAMINE DIMESYLATE

    Brand Name : VYVANSE

    Dosage Form : TABLET (CHEWABLE)

    Dosage Strength : 50MG

    Packaging :

    Approval Date :

    Application Number : 2490269

    Regulatory Info : Schedule G (CDSA I)

    Registration Country : Canada

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    09

    TAKEDA CANADA INC

    Japan
    MAGHREB PHARMA
    Not Confirmed
    arrow

    TAKEDA CANADA INC

    Japan
    arrow
    MAGHREB PHARMA
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag Japan
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : Schedule G (CDSA I)

    Registration Country : Canada

    LISDEXAMFETAMINE DIMESYLATE

    Brand Name : VYVANSE

    Dosage Form : TABLET (CHEWABLE)

    Dosage Strength : 60MG

    Packaging :

    Approval Date :

    Application Number : 2490277

    Regulatory Info : Schedule G (CDSA I)

    Registration Country : Canada

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    10

    TAKEDA CANADA INC

    Japan
    MAGHREB PHARMA
    Not Confirmed
    arrow

    TAKEDA CANADA INC

    Japan
    arrow
    MAGHREB PHARMA
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag Japan
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : Schedule G (CDSA I)

    Registration Country : Canada

    LISDEXAMFETAMINE DIMESYLATE

    Brand Name : VYVANSE

    Dosage Form : CAPSULE

    Dosage Strength : 20MG

    Packaging : 100

    Approval Date :

    Application Number : 2347156

    Regulatory Info : Schedule G (CDSA I)

    Registration Country : Canada

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF